To Örebro University
oru.se
Örebro University Publications
Planned maintenance
A system upgrade is planned for 10/12-2024, at 12:00-13:00. During this time DiVA will be unavailable.
Please wait ...
Simple search
Advanced search -
Research publications
Advanced search -
Student theses
Statistics
English
Svenska
Norsk
Jump to content
Change search
Search
Search
Only documents with full text in DiVA
Cite
Export
BibTex
CSL-JSON
CSV 1
CSV 2
CSV 3
CSV 4
CSV 5
CSV all metadata
CSV all metadata version 2
RIS
Mods
MARC-XML
ETDMS
Link to record
Permanent link
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-95035
Direct link
http://oru.diva-portal.org/smash/record.jsf?pid=diva2:1603336
Cite
Citation style
apa
ieee
modern-language-association-8th-edition
vancouver
Other style
apa
ieee
modern-language-association-8th-edition
vancouver
Other style
More styles
Language
de-DE
en-GB
en-US
fi-FI
nn-NO
nn-NB
sv-SE
Other locale
de-DE
en-GB
en-US
fi-FI
nn-NO
nn-NB
sv-SE
Other locale
More languages
Output format
html
text
asciidoc
rtf
html
text
asciidoc
rtf
Create
Close
Palbociclib dose patterns in Swedish patients with metastatic breast cancer: Evidence from the SIRI study
Valachis, Antonis
Örebro University, School of Medical Sciences. Örebro University Hospital. Department of Oncology.
ORCID iD:
0000-0001-6059-0194
Lindman, H.
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Wahl, H. Fues
Quantify Research, Quantify Research, Stockholm, Sweden.
Lauppe, R.
Quantify Research, Quantify Research, Stockholm, Sweden.
Lilja, M.
Quantify Research, Quantify Research, Stockholm, Sweden.
Nyqvist, D.
Medical Affairs, Pfizer Innovations AB, Sollentuna, Sweden.
Jakobsson, M.
Health & Value, Pfizer Innovations AB, Sollentuna, Sweden.
Show others and affiliations
2021 (English)
In:
Annals of Oncology, ISSN 0923-7534, E-ISSN 1569-8041, Vol. 32, no Suppl. 5, p. S466-S466, article id 246P
Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
Elsevier, 2021. Vol. 32, no Suppl. 5, p. S466-S466, article id 246P
National Category
Cancer and Oncology
Identifiers
URN:
urn:nbn:se:oru:diva-95035
DOI:
10.1016/j.annonc.2021.08.529
ISI:
000700527700225
OAI: oai:DiVA.org:oru-95035
DiVA, id:
diva2:1603336
Funder
Pfizer AB
Available from:
2021-10-15
Created:
2021-10-15
Last updated:
2021-10-15
Bibliographically approved
Open Access in DiVA
No full text in DiVA
Other links
Publisher's full text
Authority records
Valachis, Antonis
Search in DiVA
By author/editor
Valachis, Antonis
By organisation
School of Medical Sciences
Örebro University Hospital
In the same journal
Annals of Oncology
On the subject
Cancer and Oncology
Search outside of DiVA
Google
Google Scholar
doi
urn-nbn
Altmetric score
doi
urn-nbn
Total: 19 hits
Cite
Export
BibTex
CSL-JSON
CSV 1
CSV 2
CSV 3
CSV 4
CSV 5
CSV all metadata
CSV all metadata version 2
RIS
Mods
MARC-XML
ETDMS
Link to record
Permanent link
https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-95035
Direct link
http://oru.diva-portal.org/smash/record.jsf?pid=diva2:1603336
Cite
Citation style
apa
ieee
modern-language-association-8th-edition
vancouver
Other style
apa
ieee
modern-language-association-8th-edition
vancouver
Other style
More styles
Language
de-DE
en-GB
en-US
fi-FI
nn-NO
nn-NB
sv-SE
Other locale
de-DE
en-GB
en-US
fi-FI
nn-NO
nn-NB
sv-SE
Other locale
More languages
Output format
html
text
asciidoc
rtf
html
text
asciidoc
rtf
Create
Close
v. 2.44.0
|
WCAG
|
Örebro University Library
|
DiVA Portal
|
DiVA Log in
|
Register in DiVA
|
Contact us
DiVA
Logotyp